Self-Myofascial Release Plus Exercise Versus Exercise Alone in Type 2 Diabetes

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age30-65
SponsorIzmir Katip Celebi University

About this trial

This randomized controlled trial aims to investigate the effects of adding self-myofascial release applied to the plantar fascia and gastrosoleus muscles to an exercise program on foot function, physical performance, and plantar fascia thickness in individuals with type 2 diabetes. Participants aged 30 to 65 years with controlled type 2 diabetes will be randomly allocated to either an exercise-only group or an exercise plus self-myofascial release group. Both groups will complete an eight-week supervised exercise program three times per week. The intervention group will additionally perform self-myofascial release using a foam roller before exercise sessions. Outcomes will include foot function, balance, functional mobility, gait performance, and plantar fascia thickness assessed by ultrasonography before and after the intervention.

Eligibility criteria

Qualifiers

Individuals aged 30 to 65 years

Diagnosed with type 2 diabetes mellitus for at least 1 year

Controlled type 2 diabetes mellitus

Able to ambulate independently without assistive devices

Disqualifiers

Severe pes planus or pes cavus defined by the Foot Posture Index-6 (FPI-6) (score ≥ +10 or ≤ -5)

History of plantar fasciitis

Plantar fascia ulceration

Peripheral neuropathy

Trial design

Treatments tested in this trial

  • Exercise Program
  • Self-Myofascial Release

Treatment groups

40 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Izmir Katip Celebi University

Lead sponsor

Cigli Regional Training Hospital

Collaborator